SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-008143
Filing Date
2020-03-02
Accepted
2020-03-02 16:05:50
Documents
12
Period of Report
2020-02-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K 2020 PROXY VOTE enta-8k_20200226.htm   iXBRL 8-K 73486
  Complete submission text file 0001564590-20-008143.txt   200469

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enta-20200226.xsd EX-101.SCH 5960
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20200226_lab.xml EX-101.LAB 18708
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20200226_pre.xml EX-101.PRE 11167
5 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20200226_htm.xml XML 3400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 20676805
SIC: 2834 Pharmaceutical Preparations